United States Pharmaceuticals & Healthcare Articles

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Agenus Completes 4-Antibody Acquisition

Agenus, a company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anticancer vaccines and adjuvants, has completed its previously announced acquisition of...

Read article ›
FDA Approves Velphoro

On November 27, the FDA approved Velphoro (PA21; sucroferric oxyhydroxide) for the treatment of hyperphosphataemia in chronic kidney disease patients on dialysis. The product, owned by Vifor...

Read article ›
Apricus' Vitaros Approved In Italy

Apricus Biosciences has reported that the Italian Medicines Agency (AIFA) has apprved Vitaros (alprostadil), indicated for the treatment of patients with erectile dysfunction (ED). The company has...

Read article ›

Pages

Filter results

By Geography

By Sector

By Information Type